Abstract
Background
This is the first case–control study on the use of a fibrin sealant (Tisseel®) on uterine suture during laparoscopic myomectomy (LM), with the primary endpoint to evaluate the intraoperative bleeding and postoperative blood loss. In addition, we evaluated the time required to achieve hemostasis using Tisseel® and how much it can influence operative time.
Methods
From December 2009 to January 2011, consecutive patients older than 18 years with symptomatic isolate intramural myoma with maximal diameter ≤6 cm and ≥4 cm and with a sonographically diagnosed free myometrium margin ≥0.5 cm were included in the study. We selected from our institute’s database a group of consecutive patients with homogeneous features of the study group, who underwent laparoscopic myomectomy without Tisseel® application.
Results
Fifteen women with symptomatic myoma were enrolled in the study (group A). Regarding the control group (group B), we selected a homogenous group of 15 patients with the same preoperative characteristics of the study group. Mean operative time was 47.7 min and 62.1 min, for groups A and B respectively (p < 0.05). Mean time required to achieve complete haemostasis was 195.5 s in group A and 361.8 in control group B (p < 0.0001). Mean estimated blood loss was 111.3 mL and 230 mL in groups A and B, respectively (p < 0.05). Mean hemoglobin decrease was 1.36 g/dL and 2.04 g/dL in groups A and B, respectively (p < 0.05).
Conclusions
The use of Tisseel® during LM may represent a valid alternative solution for obtaining hemostasis, reducing intra- and postoperative bleeding. Furthermore, it may help the surgeon to obtain a rapid healing of the injured surfaces, probably reducing the use of electrocoagulation and traumatisms.
Similar content being viewed by others
References
Parker WH (2007) Uterine myomas: management. Fertil Steril 88(2):255–271
Alessandri F, Lijoi D, Mistrangelo E, Ferrero S, Ragni (2006) Randomized study of laparoscopic versus minilaparotomic myomectomy for uterine myomas. J Minim Invasive Gynecol 13(2):92–97
Dubuisson JB, Chapron C, Fauconnier A, Kreiker G (1997) Laparoscopic myomectomy and myolysis. Curr Opin Obstet Gynecol 9(4):233–238
Dubuisson JB, Chapron C, Fauconnier A, Babaki-Fard K (2001) Laparoscopic myomectomy fertility results. Ann N Y Acad Sci 943:269–275
Rossetti A, Sizzi O, Soranna L, Cucinelli F, Mancuso S, Lanzone A (2001) Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod 16(4):770–774
Seinera P, Arisio R, Decko A, Farina C, Crana F (1997) Laparoscopic myomectomy: indications, surgical technique and complications. Hum Reprod 12(9):1927–1930
Kongnyuy EJ, van den Broek N, Wiysonge CS (2008) A systematic review of randomized controlled trials to reduce hemorrhage during myomectomy for uterine fibroids. Int J Gynaecol Obstet 100:4–9
Hurst BS, Matthews ML, Marshburn PB (2005) Laparoscopic myomectomy for symptomatic uterine myomas. Fertil Steril 83(1):1–23
Newman RM, Traverso LW (1999) Principles of laparoscopic hemostasis. In: Scott-Conner CEH (ed) The SAGES manual. Springer, New York, pp 57–61
Agus GB, Bono AV, Mira E, Olivero S, Peilowich A, Homdrum E, Benelli C (1996) Hemostatic efficacy and safety of TachoComb in surgery. Int Surg 81:316–319
Schwaitzberg SD, Chan MW, Cole DJ, Read M, Nichols T, Bellinger D, Connolly RJ (2004) Comparison of poly-N-acetyl glucosamine with commercially available topical hemostats for achieving hemostasis in coagulopathic models of splenic hemorrhage. J Trauma 57:S29–S32
Bingener-Casey J, Richards ML, Strodel WE, Schwesinger WH, Sirinek KR (2002) Reasons for conversion from laparoscopic to open cholecystectomy: a 10-year review. J Gastrointest Surg 6:800–805
Taylor A, Sharma A, Tsirkas P, Arora R, De Spiezio A, Mastrogamvrakis G (2005) Surgical and radiological management of uterine fibroids: a UK survey of current consultant practice. Acta Obstet Gynecol Scand 84:478–482
Oz MC, Rondinome JF, Shargill NS (2003) FloSeal matrix: new generation topical hemostatic sealant. J Card Surg 18:486–493
Renkens KL, Paynor TD, Leipzig TJ, Feuer H, Morone MA, Koers JM (2001) A multicenter, prospective, randomized trial evaluating a new hemostatic agent for spinal surgery. Spine 26:1645–1650
Jorgensen S, Bascom DA, Partsafas A, Wax MK (2003) The effect of 2 sealants (FloSeal and Tisseel) on fasciocutaneous flap revascularization. Arch Facial Plast Surg 5:399–402
Chandra RK, Conley DB, Haines GK, Kern RC (2005) Long-term effects of FloSeal packing after endoscopic sinus surgery. Am J Rhinol 19:240–243
Fiss I, Danne M, Stendel R (2007) Use of gelatin-thrombin matrix hemostatic sealant in cranial neurosurgery. Neurol Med Chir 47:462–467
Dunn C, Goa K (1999) Fibrin sealant: a review of its use in surgery and endoscopy. Drugs 58:863–886
Young B, Roque H, Abdelhak Y, Poiolek D, Demopulos R, Lockwood C (2000) Minimally invasive endoscopy in the treatment of preterm premature rupture of membranes by application of fibrin sealant. J Perinatal Med 28:326–330
Adamyan L, Myinbayev O, Ishrat J, Kulakov V (1992) Comparative effects of different methods anastomosis on rat uterine horn. Int J Fertil 37:368–372
Peacock KE, Hurst BS, Marshburn PB, Matthews ML (2006) Effects of fibrin sealant on single-layer uterine incision closure in the New Zealand white rabbit. Fertil Steril 85(Suppl 1):1261–1264
Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Takeda S (2008) Influencing factors of adhesion development and the efficacy of adhesion-preventing agents in patients undergoing laparoscopic myomectomy as evaluated by a second-look laparoscopy. Fertil Steril 89(5):1247–1253
Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kinoshita K (2005) Adhesion-prevention effects of fibrin sealants after laparoscopic myomectomy as determined by second-look laparoscopy: a prospective, randomized, controlled study. J Reprod Med 50(8):571–577
Tsuji S, Takahashi K, Yomo H, Fujiwara M, Kita N, Takebayashi K, Miyazaki K, Noda Y (2005) Effectiveness of antiadhesion barriers in preventing adhesion after myomectomy in patients with uterine leiomyoma. Eur J Obstet Gynecol Reprod Biol 123(2):244–248
Raga F, Sanz-Cortes M, Bonilla F, Casan EM, Bonilla-Musoles F (2009) Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril 92(1):356–360
Jin C, Hu Y, Chen XC, Zheng FY, Lin F, Zhou K, Chen FD, Gu HZ (2009) Laparoscopic versus open myomectomy–a meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol 145(1):14–21
Paul GP, Naik SA, Madhu KN, Thomas T (2010) Complications of laparoscopic myomectomy: a single surgeon’s series of 1001 cases. Aust N Z J Obstet Gynaecol 50(4):385–390
Tinelli A, Malvasi A, Hudelist G, Cavallotti C, Tsin DA, Schollmeyer T, Bojahr B, Mettler L (2010) Laparoscopic intracapsular myomectomy: comparison of single versus multiple fibroids removal. An institutional experience. J Laparoendosc Adv Surg Tech A 20(8):705–711
Agdi M, Tulandi T (2010) Minimally invasive approach for myomectomy. Semin Reprod Med 28(3):228–234
Kongnyuy EJ, Wilysonge CS (2007) Interventions to reduce haemorrhage during myomectomy for fibroids. Cochrane Database Syst Rev 24:CD005355
Taylor E, Gomel V (2008) The uterus and fertility. Fertil Steril 89:1–16
Lethaby A, Vollenhoven B, Sowter M (2001) Preoperative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev 2:CD000547
Lethaby A, Vollenhoven B, Sowter M (2001) Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev (2):000547
De Falco M, Staibano S, Mascolo M, Mignogna C, Improda L, Ciociola F, Carbone IF, Di Lieto A (2009) Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes. Eur J Obstet Gynecol Reprod Biol 144:44–47
Friedman AJ, Rein MS, Harrison-Atlas D, Garfield JM, Doubilet PM (1989) A randomized, placebo-controlled, double-blind study evaluating leuprolide acetate depot treatment before myomectomy. Fertil Steril 52:728–749
Fedele L, Vercellini P, Bianchi S, Brioschi D, Dorta M (1990) Treatment with GnRH agonists before myomectomy and the risk of short-term myoma recurrence. Br J Obstet Gynaecol 97(5):393–396
User HM, Nadler RB (2003) Applications of FloSeal in nephron-sparing surgery. Urology 62:342–343
Spotnitz WD, Burks S (2010) State-of-the-art review: hemostats, sealants, and adhesives II. Update as well as how and when to use the components of the surgical toolbox. Clin Appl Thromb Hemost 16(5):497–514
Sileshi B, Achneck HE, Lawson JH (2008) Management of surgical hemostasis: topical agents. Vascular 16(Suppl 1):S22–S28
Alston SM, Solen KA, Sukavaneshvar S, Mohammad SF (2008) In vivo efficacy of a new autologous fibrin sealant. J Surg Res 146(1):143–148
Sizzi O, Rossetti A, Malzoni M, Minelli L, La Grotta F, Soranna L, Panunzi S, Spagnolo R, Imperato F, Landi S, Fiaccamento A, Stola E (2007) Italian multicenter study on complications of laparoscopic myomectomy. J Minim Invasive Gynecol 14(4):453–462
Rossetti A, Sizzi O, Soranna L, Cucinelli F, Mancuso S, Lanzone A (2001) Long-term results of laparoscopic myomectomy: recurrence rate in comparison with abdominal myomectomy. Hum Reprod 16:770–774
Jasonni VM, Tabanelli S, Flamigni C (1986) Use of fibrin sealant (Tissucol®/Tisseel) in the treatment of vaginal aplasia. Gynecol Obstet-Urol 3:80–83
Orlandi C, Marabini A, Vendra C, Mancini L (1986) Tissucol®, miomectomy ovarian plastic surgery. Gynecol Obstet-Urol 3:63–65
Ussia G, Salerno A, Feldmann D, Sorrenti G, Galletti G, Farruggia F (1986) Anastomosi delle tube ovariche senza fili di sutura mediante colla di fibrina umana (Tissucol®). Minerva Ginecol 38(4):325
Farquhar C, Vandekerckhove P, Watson A, Vail A, Wiseman D (2000) Barrier agents for preventing adhesions after surgery for subfertility. Cochrane Database Syst Rev 2:CD000475
Fukasawa M, Campeau JD, Yanagihara D, Rodgers KE, di Zerega GS (1990) Regulation of proliferation of peritoneal tissue repair cells by peritoneal macrophages. J Surg Res 49:81–87
Liakakos T, Thomakos N, Fine PM, Dervenis C, Young RL (2001) Peritoneal adhesions: etiology, pathophysiology, and clinical significance. Recent advances in prevention and management. Dig Surg 18:260–273
Clark RA (2000) Fibrin sealant in wound repair: a systematic survey of the literature. Expert Opin Investig Drugs 9:2371–2392
Dickneite G, Metzner HJ, Kroez M, Hein B, Nicolay U (2002) The importance of factor XIII as a component of fibrin sealants. J Surg Res 107:186–195
Han LY, Schimp V, Oh JC, Ramirez PT (2004) A gelatin matrix-thrombin tissue sealant (FloSeal) application in the management of groin breakdown after inguinal lymphadenectomy for vulvar cancer. Int J Gynecol Cancer 14:621–624
Ellegala DB, Maartens NF, Laws ER Jr (2002) Use of FloSeal hemostatic sealant in transsphenoidal pituitary surgery: technical note. Neurosurgery 51(2):513–515
Oz MC, Cosgrove DM 3rd, Badduke BR, Hill JD, Flannery MR, Palumbo R, Topic N (2000) Controlled clinical trial of a novel hemostatic agent in cardiac surgery. Ann Thorac Surg 69:1376–1382
Hsu WC, Hwang JS, Chang WC, Huang SC, Sheu BC, Torng PL (2007) Prediction of operation time for laparoscopic myomectomy by ultrasound measurements. Surg Endosc 21(9):1600–1606
Disclosures
Drs. Roberto Angioli, Francesco Plotti, Roberto Ricciardi, Corrado Terranova, Marzio Angelo Zullo, Patrizio Damiani, Roberto Montera, Federica Guzzo, Giuseppe Scaletta, and Ludovico Muzii have no conflicts of interest or financial ties to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Angioli, R., Plotti, F., Ricciardi, R. et al. The use of novel hemostatic sealant (Tisseel®) in laparoscopic myomectomy: a case–control study. Surg Endosc 26, 2046–2053 (2012). https://doi.org/10.1007/s00464-012-2154-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-012-2154-2